...
首页> 外文期刊>Biochemical and Biophysical Research Communications >Chetomin induces apoptosis in human triple-negative breast cancer cells by promoting calcium overload and mitochondrial dysfunction
【24h】

Chetomin induces apoptosis in human triple-negative breast cancer cells by promoting calcium overload and mitochondrial dysfunction

机译:通过促进钙过载和线粒体功能障碍诱导人三阴性乳腺癌细胞中的细胞凋亡

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Abstract Human triple-negative breast cancer (TNBC) is poorly diagnosed and unresponsive to conventional hormone therapy. Chetomin (CHET), a fungal metabolite synthesized by Chaetomium cochliodes , has been reported as a promising anticancer and antiangiogenic agent but the complete molecular mechanism of its anticancer potential remains to be elucidated. In our study, we explored the anti-neoplastic action of CHET on TNBC cells. Cytotoxicity studies were performed in human TNBC cells viz. MDA-MB-231 and MDA-MB-468?cells by Sulforhodamine B assay. It exhibited antiproliferative response and induced apoptosis in both the cell types. Cell cycle analysis revealed that it increases the sub G0/G1 phase cell population. Modulation of mitochondrial membrane potential, activation of caspase 3/7 and a remarkable increase in the expression of cleaved PARP and increased chromatin condensation was observed after CHET treatment in MDA-MB-231 and MDA-MB-468?cells. Additionally, an elevated level of intracellular Ca 2+ played an important role in CHET mediated cell death response. Calcium overload in mitochondria led to release of cytochrome c which in turn triggered caspase-3 mediated cell death. Inhibition of calcium signalling using BAPTA-AM reduced apoptosis confirming the involvement of calcium signalling in CHET induced cell death. Chetomin also inhibited PI3K/mTOR cell survival pathway in human TNBC cells. The overall findings suggest that Chetomin inhibited the growth of human TNBC cells by caspase-dependent apoptosis and modulation of PI3K/mTOR signalling and could be used as a novel chemotherapeutic agent for the treatment of human TNBC in future. Graphical abstract Display Omitted Highlights ? Chetomin induced apoptosis in human triple-negative breast cancer cells. ? Chetomin promoted ER stress and cellular calcium overload. ? Chetomin mediated mitochondrial dysfunction triggered intrinsic pathway of cell death. ? Chetomin inhibited PI3K/mTOR pathways.
机译:摘要人类三重阴性乳腺癌(TNBC)对常规激素治疗诊断并不响应。 Chetomin(CHET)是由Chaetomium Cochliodes合成的真菌代谢物,已被报告为一个有前途的抗癌和抗血管生成剂,但其抗癌潜力的完整分子机制仍有待阐明。在我们的研究中,我们探讨了CHET对TNBC细胞的抗肿瘤作用。细胞毒性研究在人TNBC细胞QZ中进行。 MDA-MB-231和MDA-MB-468?苏尔磺胺胺B测定的细胞。它表现出抗增殖反应,并在细胞类型中诱导细胞凋亡。细胞循环分析显示它增加了亚G0 / G1相细胞群。在MDA-MB-231和MDA-231和MDA-MB-468?细胞中,在CHET处理后,观察到线粒体膜电位,激活Caspase 3/7的激活和显着增加,以及增加染色质缩合的增加和增加的染色质缩合。另外,细胞内Ca 2+水平在CHET介导的细胞死亡反应中起重要作用。线粒体中的钙过载导致细胞色素C的释放,又触发了Caspase-3介导的细胞死亡。使用Bapta-AM降低凋亡抑制钙信号传导证实钙信号传导在CHET诱导的细胞死亡中的参与。 Chetomin还抑制人TNBC细胞中的PI3K / mTOR细胞存活途径。总体研究结果表明,Chetomin通过Caspase依赖性凋亡和PI3K / MTOR信号传导的调节抑制人TNBC细胞的生长,并可作为未来治疗人TNBC的新型化学治疗剂。图形抽象显示省略了亮点?甲基甲胺蛋白诱导人三阴性乳腺癌细胞的细胞凋亡。还甲基蛋白促进了ER应激和细胞钙过载。还甲基甲胺蛋白介导的线粒体功能障碍触发了细胞死亡的内在途径。还甲基醛抑制PI3K / mTOR途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号